Los puntos clave no están disponibles para este artículo en este momento.
Figure S13. Boxplots showing usage of epithelial cNMF programs in epithelial cells of fast and slow progressors (A) post-chemotherapy (FU1) and (B) postimmunotherapy (FU2).
An et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: